HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?

Saved in:
Bibliographic Details
Title: HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
Authors: da Costa AM; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Cancer Registry, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil., Fregnani JHTG; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil., Pastrez PRA; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil., Mariano VS; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil., Silva EM; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil., Neto CS; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil., Guimarães DP; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil.; Department of Endoscopy, Barretos Cancer Hospital - Pious XII Foundation, Barretos, São Paulo, Brazil., Villa LL; Molecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, Brazil.; Department of Radiology and Oncology, School of Medicine, University of São Paulo, São Paulo, Brazil., Sichero L; Molecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, Brazil., Syrjanen KJ; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil.; Department of Clinical Research - Biohit Oyj, Helsinki, Finland., Longatto-Filho A; Teaching and Research Institute, Barretos Cancer Hospital - Pius XII Foundation, Rua Antenor Duarte Vilela, 1331, Dr. Paulo Prata, Barretos, São Paulo 14784-400 Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital - Pius XII Foundation, São Paulo, Brazil.; Medical Laboratory of Medical Investigation (LIM) 14, Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.; Research Institute of Life and Health Sciences (ICVS), University of Minho, Braga, Portugal.; ICVS / 3B's - Associated Laboratory to the Government of Portugal, Braga/Guimarães, Portugal.
Source: Infectious agents and cancer [Infect Agent Cancer] 2017 Oct 13; Vol. 12, pp. 54. Date of Electronic Publication: 2017 Oct 13 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101276559 Publication Model: eCollection Cited Medium: Print ISSN: 1750-9378 (Print) Linking ISSN: 17509378 NLM ISO Abbreviation: Infect Agent Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-9378
DOI:10.1186/s13027-017-0163-4